F. Barlesi

Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial.

H. Groen, A. Chella, M. Ahn, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC).

K. Goto, V. Papadimitrakopoulou, F. Barlesi, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

IMpower150: analysis of efficacy in patients (pts) with liver metastases (mets)

M. Socinski, V. Papadimitrakopoulou, M. Nishio, 2020, Pneumologie.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. G. Levra, Johan Vansteenkiste, Sanne A.E. Peters, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC).

H. Wakelee, L. Sequist, M. Diehn, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications

D. Planchard, A. Italiano, B. Besse, 2023, The Journal of Liquid Biopsy.

[Systemic treatment of brain metastases from lung cancer].

F. Barlesi, B. Besse, J. Spano, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer.

G. Scagliotti, J. Milanowski, F. Shepherd, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. G. Levra, Johan Vansteenkiste, Sanne A.E. Peters, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer.

G. Scagliotti, E. Felip, A. Santoro, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.

J. Blay, G. Ferretti, J. Mazières, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.